Dominican Republic vs Switzerland: The number of people with susceptibility test result for rifampicin
Dominican Republic
87.56
in 2021
Switzerland
87.3
in 2021
Dominican Republic rank
78th
Switzerland rank
79th
The number of people with susceptibility test result for rifampicin over time
- Dominican Republic
- Switzerland
How they compare
Dominican Republic currently reports 87.56 against 87.3 in Switzerland, a difference of 0.26.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Switzerland ahead.
Dominican Republic ranks 78th and Switzerland ranks 79th of 146 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Dominican Republic | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 27.86 | 92.97 | 65.11 | Switzerland |
| 2020s | 79.91 | 88.89 | 8.98 | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Dominican Republic or Switzerland?
- Dominican Republic, at 87.56 against 87.3 in Switzerland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Dominican Republic and Switzerland?
- 0.26, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Switzerland?
- 5 years are reported by both, from 2017 to 2021.
- How do Dominican Republic and Switzerland rank globally for the number of people with susceptibility test result for rifampicin?
- Dominican Republic ranks 78th and Switzerland ranks 79th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.